GO:0030346 protein phosphatase 2B binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030346 (protein phosphatase 2B binding) is a molecular function describing the selective binding of a protein to protein phosphatase 2B (PP2B), also known as calcineurin or protein phosphatase 3.
• PP2B/calcineurin is a calcium/calmodulin-dependent serine/threonine phosphatase that is the target of immunosuppressant drugs such as FK506 and cyclosporin A.
• Binding partners of PP2B act as anchoring proteins, substrates, or regulators that control phosphatase activity, substrate specificity, and subcellular localization.
• The interaction between PP2B and its binding proteins is critical for diverse physiological processes, including T-cell activation, autophagy, vesicle secretion, and cholesterol efflux.
• Dysregulation of PP2B binding is implicated in immune disorders, cardiovascular disease, and cancer, making it a target for therapeutic intervention.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of PP2B binding interfaces and their functional consequences.
Description
Protein phosphatase 2B (PP2B), also known as calcineurin, is a calcium/calmodulin-dependent serine/threonine phosphatase that plays a central role in signal transduction. The Gene Ontology (GO) term GO:0030346, protein phosphatase 2B binding, defines the molecular function of selectively interacting with PP2B. This binding event is fundamental to the regulation of PP2B activity, substrate recruitment, and spatial organization of signaling complexes. Understanding PP2B binding is essential for researchers studying calcium signaling, immune responses, and autophagy, as well as for drug discovery targeting calcineurin. The interaction is mediated by specific anchoring proteins and substrates that contain PP2B-binding motifs, such as the PxIxIT and LxVP sequences. These interactions are highly regulated and can be disrupted by immunosuppressive drugs, which form complexes with immunophilins that bind and inhibit PP2B. Consequently, GO:0030346 represents a critical node in cellular signaling networks, with implications for human health and disease.
protein phosphatase 2B binding At A Glance
| GO ID | GO:0030346 |
|---|---|
| GO term | protein phosphatase 2B binding |
| Ontology | molecular_function |
| Synonym | calcineurin binding, protein phosphatase 3 binding |
| Major function | Binding to protein phosphatase 2B (PP2B/calcineurin), a calcium/calmodulin-dependent serine/threonine phosphatase |
| Related diseases | Immune disorders, cardiovascular disease, cancer, and metabolic dysfunction |
| Key regulators | Calcium/calmodulin, immunophilins (FKBP12, cyclophilin A), and anchoring proteins (AKAP79, Munc18c) |
| Experimental models | Knockout, point mutation, knock-in, and overexpression cell models; CRISPR library screening |
What Is GO:0030346?
According to the Gene Ontology, GO:0030346 (protein phosphatase 2B binding) is a molecular function defined as binding to protein phosphatase 2B. It encompasses the physical interaction between a protein and PP2B (calcineurin), including anchoring, substrate recognition, and regulatory events. This term is synonymous with calcineurin binding and protein phosphatase 3 binding.
Why Is protein phosphatase 2B binding Important in Cell Biology?
GO:0030346 is important because PP2B binding governs the activity and specificity of calcineurin, a phosphatase that controls numerous cellular processes, including T-cell activation, autophagy, and vesicle secretion. Disruption of PP2B binding interfaces can lead to immune deficiencies, cardiovascular pathologies, and cancer, highlighting its therapeutic relevance. Moreover, PP2B binding proteins serve as scaffolds that localize calcineurin to specific substrates, ensuring signal fidelity. Thus, studying this term provides mechanistic insights into calcium signaling and offers targets for drug development.
• PP2B binding is essential for T-cell activation and immune responses, as calcineurin dephosphorylates NFAT transcription factors.
• Binding partners such as AKAP79 anchor PP2B to specific subcellular compartments, modulating its activity.
• The interaction between PP2B and Munc18c regulates von Willebrand factor secretion from endothelial cells.
• PP2B binding to TFEB controls autophagy and lysosomal biogenesis in response to calcium signals.
• Dysregulated PP2B binding is implicated in cardiac hypertrophy and heart failure.
• In cancer, PP2B binding proteins can influence cell proliferation and survival pathways.
• Immunosuppressant drugs (FK506, cyclosporin A) target PP2B by forming inhibitory complexes, underscoring the importance of binding interfaces.
• PP2B binding is a potential therapeutic target for autoimmune diseases and transplant rejection.
• Understanding PP2B binding mechanisms can inform the design of selective inhibitors.
• CRISPR screens can identify novel PP2B binding proteins and their functional roles.
What Happens During protein phosphatase 2B binding?
Recognition and Anchoring
In simple terms: Binding proteins recognize and attach to PP2B, positioning it near its targets.
PP2B binding typically involves short linear motifs, such as PxIxIT and LxVP, that mediate interaction with the catalytic domain of calcineurin. Anchoring proteins like AKAP79 bind PP2B via residues 315-360, which both anchors the phosphatase and inhibits its activity. This recognition step ensures that PP2B is localized to specific signaling microdomains.
Conformational Changes and Activation
In simple terms: Binding can change PP2B's shape and turn its activity on or off.
Upon binding to calcium/calmodulin, PP2B undergoes conformational changes that relieve autoinhibition and expose the active site. Binding partners can further modulate this process; for example, AKAP79 binding inhibits PP2B activity, while other partners may enhance substrate accessibility. The interplay between calcium signaling and binding protein interactions determines the net phosphatase output.
Substrate Recruitment and Dephosphorylation
In simple terms: PP2B binding proteins bring substrates to the phosphatase for dephosphorylation.
Scaffold proteins such as AKAP79 and Munc18c recruit specific substrates to PP2B, facilitating dephosphorylation events. For instance, PP2B dephosphorylates TFEB, promoting its nuclear translocation and activation of autophagy genes. Similarly, PP2B-dependent dephosphorylation of ABCA1 enhances cholesterol efflux in macrophages.
Regulation by Immunophilins and Drugs
In simple terms: Immunosuppressant drugs bind immunophilins, which then bind and inhibit PP2B.
The immunosuppressants FK506 and cyclosporin A form complexes with FKBP12 and cyclophilin A, respectively, which bind to and inhibit PP2B. This inhibition blocks downstream signaling, such as NFAT dephosphorylation, leading to immunosuppression. These drug-immunophilin-PP2B interactions highlight the druggability of PP2B binding interfaces.
Key Genes Involved in GO:0030346 protein phosphatase 2B binding
The following genes and proteins are key players in protein phosphatase 2B binding, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PPP3CA | Catalytic subunit of PP2B (calcineurin A alpha) | Core phosphatase; target of binding proteins and drugs |
| PPP3CB | Catalytic subunit of PP2B (calcineurin A beta) | Isoform-specific functions in signaling |
| PPP3R1 | Regulatory subunit of PP2B (calcineurin B) | Calcium-binding subunit; modulates activity |
| AKAP79 | Anchoring protein that binds PP2B | Regulates PP2B localization and activity |
| Munc18c | Syntaxin-binding protein involved in vesicle secretion | Forms complex with PP2B to regulate vWF secretion |
| TFEB | Transcription factor regulating autophagy and lysosomal biogenesis | Dephosphorylated by PP2B upon binding |
| ABCA1 | ATP-binding cassette transporter A1 | Dephosphorylated by PP2B, promoting cholesterol efflux |
| NFATc1 | Nuclear factor of activated T-cells | Dephosphorylated by PP2B, leading to T-cell activation |
| FKBP12 | Immunophilin | Forms complex with FK506 to inhibit PP2B |
| PPIA | Cyclophilin A | Forms complex with cyclosporin A to inhibit PP2B |
| RCAN1 | Regulator of calcineurin 1 | Inhibits PP2B activity through binding |
| CABIN1 | Calcineurin-binding protein 1 | Inhibits PP2B and regulates transcription |
| AKAP5 | A-kinase anchoring protein 5 | Anchors PP2B and other signaling proteins |
| PPP3CC | Catalytic subunit of PP2B (calcineurin A gamma) | Testis-specific isoform; binding partners less characterized |
| PPP3R2 | Regulatory subunit of PP2B (calcineurin B type 2) | Testis-specific; may modulate PP2B binding |
How Is protein phosphatase 2B binding Regulated?
The binding of proteins to PP2B is regulated by intracellular calcium levels, which activate calmodulin and relieve autoinhibition of the phosphatase. Additionally, phosphorylation of binding proteins or PP2B itself can modulate interactions. Immunophilins and their drug complexes provide an additional layer of regulation by forming inhibitory complexes with PP2B. Furthermore, scaffolding proteins like AKAP79 can both anchor and inhibit PP2B, creating a dynamic regulatory hub.
protein phosphatase 2B binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PPP3CA | Immunosuppression, cardiac hypertrophy | Knockout and point mutation cell models |
| Munc18c | Thrombosis, von Willebrand factor secretion | Knockout endothelial cells |
| TFEB | Autophagy-related diseases, lysosomal storage disorders | Knock-in of phospho-mutant TFEB |
| ABCA1 | Atherosclerosis, cholesterol efflux | Overexpression and knockout macrophages |
| AKAP79 | Cardiac arrhythmias, synaptic plasticity | Knock-in of binding-deficient AKAP79 |
Immune Disorders and Transplant Rejection
PP2B binding is central to T-cell activation via NFAT dephosphorylation. Inhibitors of PP2B binding, such as FK506 and cyclosporin A, are used to prevent transplant rejection and treat autoimmune diseases. Dysregulated PP2B binding can lead to immunodeficiency or autoimmunity.
Cardiovascular Disease
PP2B binding proteins like Munc18c regulate von Willebrand factor secretion from endothelial cells, impacting thrombosis and hemostasis. In the heart, PP2B binding to AKAP79 modulates calcium signaling and cardiac hypertrophy.
Cancer and Metabolic Dysfunction
PP2B-dependent dephosphorylation of ABCA1 promotes cholesterol efflux, and its dysregulation is linked to atherosclerosis. In cancer, PP2B binding proteins can influence cell proliferation and survival, making them potential therapeutic targets.
From protein phosphatase 2B binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PP2B binding affect T-cell activation? | PPP3CA knockout Jurkat cells |
| How does a point mutation in the PP2B binding interface alter substrate specificity? | Point-mutant knock-in of PPP3CA |
| Can a tagged PP2B binding protein be used to isolate PP2B complexes? | Knock-in of FLAG-tagged AKAP79 |
| Does overexpression of a PP2B binding protein enhance autophagy? | Overexpression of TFEB in HeLa cells |
| What genes are required for PP2B-mediated cholesterol efflux? | CRISPR library screening in macrophages |
| Does disruption of PP2B-Munc18c complex reduce vWF secretion? | Munc18c knockout endothelial cells |
How to Study the protein phosphatase 2B binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-IP/MS | Protein-protein interactions | Identifying PP2B binding partners |
| Phosphatase assay | Enzymatic activity | Assessing regulation by binding proteins |
| CRISPR screen | Gene function at scale | Discovering regulators of PP2B binding |
| FRET biosensor | Real-time binding dynamics | Monitoring PP2B interactions in live cells |
| Western blot | Protein expression and phosphorylation | Validating dephosphorylation of substrates |
| Immunofluorescence | Subcellular localization | Visualizing PP2B and binding partners |
| Surface plasmon resonance | Binding affinity and kinetics | Quantifying PP2B-peptide interactions |
Co-immunoprecipitation and Mass Spectrometry
Co-immunoprecipitation (co-IP) followed by mass spectrometry is used to identify PP2B binding partners and map interaction interfaces. This method can reveal dynamic changes in binding under different conditions.
Phosphatase Activity Assays
PP2B phosphatase activity can be measured using colorimetric or fluorometric substrates, such as RII phosphopeptide, to assess the impact of binding proteins on catalytic activity.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate PP2B binding and downstream signaling. These screens are powerful for discovering novel components of the PP2B interactome.
Live-Cell Imaging and FRET
FRET-based biosensors can monitor PP2B binding dynamics in live cells, providing spatiotemporal information about interactions. This approach is useful for studying real-time regulation by calcium.
How CRISPR Can Be Used to Study GO:0030346 protein phosphatase 2B binding
Knockout
CRISPR knockout of genes encoding PP2B subunits or binding proteins can abolish specific interactions, revealing their functional importance. For example, PPP3CA knockout cells are used to study calcineurin-dependent signaling.
Point Mutation
Introducing point mutations in PP2B binding motifs (e.g., PxIxIT) via CRISPR can disrupt binding without affecting protein expression, allowing precise structure-function analysis.
Knock-in
Knock-in of tagged or mutant versions of PP2B binding proteins (e.g., FLAG-AKAP79) enables affinity purification and imaging of endogenous complexes.
Overexpression
Overexpression of PP2B binding proteins or substrates can amplify signaling pathways and facilitate biochemical studies.
How EDITGENE Supports protein phosphatase 2B binding Research
Researchers studying protein phosphatase 2B binding-related genes often need to determine whether a candidate gene is causally involved in PP2B interactions and downstream signaling. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for protein phosphatase 2B binding research.
Frequently Asked Questions About protein phosphatase 2B binding
What is protein phosphatase 2B binding?
Protein phosphatase 2B binding (GO:0030346) is a molecular function describing the selective interaction of a protein with PP2B (calcineurin), a calcium/calmodulin-dependent phosphatase.
What genes are involved in protein phosphatase 2B binding?
Key genes include PPP3CA, PPP3CB, PPP3R1, AKAP79, Munc18c, TFEB, and ABCA1, among others.
How is protein phosphatase 2B binding regulated?
It is regulated by calcium/calmodulin, phosphorylation, and interactions with immunophilins and scaffolding proteins.
What diseases are associated with protein phosphatase 2B binding?
Dysregulation is linked to immune disorders, cardiovascular disease, cancer, and metabolic dysfunction.
What methods are used to study protein phosphatase 2B binding?
Common methods include co-immunoprecipitation, mass spectrometry, phosphatase assays, FRET biosensors, and CRISPR screens.
What is the role of calcineurin in T-cell activation?
Calcineurin (PP2B) dephosphorylates NFAT transcription factors, leading to their nuclear translocation and T-cell activation.
How do immunosuppressant drugs target PP2B binding?
FK506 and cyclosporin A form complexes with immunophilins that bind and inhibit PP2B, blocking downstream signaling.
Can CRISPR be used to study PP2B binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of PP2B binding interfaces.
What is the role of AKAP79 in PP2B binding?
AKAP79 anchors PP2B to specific subcellular locations and inhibits its phosphatase activity via residues 315-360.
How does PP2B binding affect autophagy?
PP2B binding to TFEB promotes its dephosphorylation and nuclear translocation, activating autophagy genes.
Conclusion
GO:0030346 (protein phosphatase 2B binding) is a critical molecular function that governs the interaction of diverse proteins with the calcium/calmodulin-dependent phosphatase PP2B. This binding event regulates key signaling pathways involved in immunity, autophagy, secretion, and metabolism, with profound implications for human disease. Leveraging CRISPR-based models and advanced screening technologies, researchers can now dissect the precise mechanisms and therapeutic potential of PP2B binding interfaces.
References
- 1. Stoddard BL et al.. 1996. Calcineurin-immunosuppressor complexes.. Curr Opin Struct Biol 6(6):770-5 PMID: 8994877
- 2. Medina DL et al.. 2015. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB.. Nat Cell Biol 17(3):288-99 PMID: 25720963
- 3. Nygren PJ et al.. 2016. Regulation of the phosphatase PP2B by protein-protein interactions.. Biochem Soc Trans 44(5):1313-1319 PMID: 27911714
- 4. Hogan PG et al.. 2005. Calcineurin.. Curr Biol 15(12):R442-3 PMID: 15964258
- 5. Klee CB et al.. 1988. Calcineurin.. Adv Enzymol Relat Areas Mol Biol 61:149-200 PMID: 2833077
- 6. Da Q et al.. 2017. Disruption of protein complexes containing protein phosphatase 2B and Munc18c reduces the secretion of von Willebrand factor from endothelial cells.. J Thromb Haemost 15(5):1032-1039 PMID: 28294518
- 7. Dell'Acqua ML et al.. 2002. Mapping the protein phosphatase-2B anchoring site on AKAP79. Binding and inhibition of phosphatase activity are mediated by residues 315-360.. J Biol Chem 277(50):48796-802 PMID: 12354762
- 8. Chen CY et al.. 2011. Wogonin promotes cholesterol efflux by increasing protein phosphatase 2B-dependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages.. J Nutr Biochem 22(11):1015-21 PMID: 21190831
